Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
America's HIV population is aging rapidly, with the median age projected to jump from 51 to 61 years by 2040, per a Johns Hopkins modeling study. Nearly half of people with HIV will be over 65, raising urgent concerns about geriatric care, physician training, and federal program funding. The shift is uneven — urban states skew older while rural states see younger, newly diagnosed populations.
A new analytic modeling study from Johns Hopkins University projects a dramatic demographic shift in the U.S. HIV population: the median age is expected to leap from 51 years in 2025 to 61 years by 2040, with nearly half (46%) of people with HIV aged over 65. Researchers credit antiretroviral therapy (ART) as "an absolute triumph of modern medicine" for extending lives — but warn that this success brings new challenges.
The aging trend isn't uniform. Urban states like California and New York are projected to see median ages hit 67 by 2040, while rural states like Arkansas and Oklahoma may stay around 39, driven by newer infections among younger people. Racial disparities persist too, with non-Hispanic Black people projected to have a median age of 54 versus 65 for white and other groups.
By the Numbers:
Why it matters: An older HIV population means a surge in complex comorbidities — cardiovascular disease, kidney disease, metabolic syndrome, and non-AIDS cancers — demanding more geriatric-informed HIV care. Experts warn of a looming physician shortage with the right training, and increased pressure on federally funded programs like the Ryan White HIV/AIDS Program.
